ArticleAmerican journal of translational research2010

VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma.

Yan Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.